Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease

Treatment strategies for inflammatory bowel disease (IBD) are rapidly evolving with the development of biologics and small molecule drugs (SMDs). However, these drugs are not guaranteed to be effective in all patients, and a “ceiling effect” of biologic monotherapy may occur. This issue highlights a...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yi-Han, Zhu, Wei-Ming, Guo, Zhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827580/
https://www.ncbi.nlm.nih.gov/pubmed/36632311
http://dx.doi.org/10.3748/wjg.v28.i48.6888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9827580/
https://www.ncbi.nlm.nih.gov/pubmed/36632311
http://dx.doi.org/10.3748/wjg.v28.i48.6888

Ejemplares similares